Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

J. Exp. Med. 205 (6): 1255-1259

Copyright © 2008 by the Rockefeller University Press.


COMMENTARY

IKKβ/NF-{kappa}B and the miscreant macrophage

Anjuli M. Timmer, and Victor Nizet

A.M. Timmer and V. Nizet are at Department of Pediatrics, School of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093

CORRESPONDENCE V.N.: vnizet{at}ucsd.edu

ABSTRACT Back to Top

Abstract: Macrophage activation relies on complex intracellular signaling processes that integrate the need for rapid inflammatory responses to pathogens with the need to resolve inflammation without permanent harm to normal tissues. Patterns of aberrant macrophage activation characterize and sustain disorders of chronic inflammation, infection, and cancer. New studies now show a role for the NF-{kappa}B activator IKKβ in promoting an alternative, immunosuppressive pattern of macrophage activation, which limits the cell's tumoricidal and bactericidal capacities. As cancers and pathogens may have evolved multiple mechanisms to manipulate macrophages for their own survival, is there anything we can do about it?


© 2008 Timmer and Nizet This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
NO Is a Macrophage Autonomous Modifier of the Cytokine Response to Streptococcal Single-Stranded RNA.
S. D. Deshmukh, S. Muller, K. Hese, K. S. Rauch, J. Wennekamp, O. Takeuchi, S. Akira, D. T. Golenbock, and P. Henneke (2012)
J. Immunol. 188, 774-780
   Abstract »    Full Text »    PDF »
Deletion of the murine scavenger receptor CD68.
L. Song, C. Lee, and C. Schindler (2011)
J. Lipid Res. 52, 1542-1550
   Abstract »    Full Text »    PDF »
Functional Characterization of Lipopolysaccharide derived from Symbiotic Bacteria in Rice as a Macrophage-activating Substance.
T. KADOWAKI, H. INAGAWA, C. KOHCHI, M. HIRASHIMA, and G.-I. SOMA (2011)
Anticancer Res 31, 2467-2476
   Abstract »    Full Text »    PDF »
Selective inhibition of NF-{kappa}B in Kupffer cells: good, but not for everything.
F. Marra (2009)
Gut 58, 1581-1582
   Full Text »    PDF »
Interferons Direct an Effective Innate Response to Legionella pneumophila Infection.
C. R. Plumlee, C. Lee, A. A. Beg, T. Decker, H. A. Shuman, and C. Schindler (2009)
J. Biol. Chem. 284, 30058-30066
   Abstract »    Full Text »    PDF »
Differential Macrophage Polarization in Male and Female BALB/c Mice Infected With Coxsackievirus B3 Defines Susceptibility to Viral Myocarditis.
K. Li, W. Xu, Q. Guo, Z. Jiang, P. Wang, Y. Yue, and S. Xiong (2009)
Circ. Res. 105, 353-364
   Abstract »    Full Text »    PDF »
Science Signaling Podcast: 15 July 2008.
J. F. Foley and A. M. VanHook (2008)
Science Signaling 1, pc6
   Abstract »    Full Text »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882